Dr. Nasha Winters, ND, FABNO, is an internationally recognized leader in integrative oncology and metabolic medicine, renowned for advancing a whole-system approach to cancer care. As the CEO of Dr. Nasha, Inc., she bridges the best of conventional oncology with the science of metabolic therapy, empowering both patients and practitioners to navigate cancer through a terrain-based, precision-focused model.
She is the co-author of the influential book The Metabolic Approach to Cancer and the co-author of Mistletoe and the Emerging Future of Integrative Oncology, a seminal work advancing the clinical understanding and application of mistletoe therapy in cancer care. Her writing has helped reshape global perspectives on cancer prevention, treatment, and long-term wellness. Her work emphasizes understanding the metabolic drivers of disease, optimizing the body’s internal environment, and applying targeted therapies—conventional and complementary—to support better outcomes.
She is also the creator of multiple professional education programs that are transforming clinical practice worldwide, including the Integrative Metabolic Oncology Course (IMOC), the Advanced Integrative Medicine Course (AIMC), and the Terrain Advocate Program. Through these offerings, she trains physicians, allied health providers, and patient advocates in personalized, data-driven cancer care rooted in metabolic health science.